Science
Healthtech · US
US neural-engineering company building the PRIMA retinal implant and brain-computer interfaces.
Funding history
| Date | Round | Amount |
|---|
| Mar 2026 | Series C Neural-engineering startup Science raised a $230M Series C to commercialise its PRIMA retinal implant and expand clinical trials. | $230M |
Investors
IQTKhosla VenturesLightspeed Venture PartnersQuiet CapitalY Combinator
Similar companies in Healthtech
Explore funding flow on EquityFlow →